Your browser doesn't support javascript.
loading
Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial.
Geng, Xuechen; Wang, Ziqiang; Feng, Li; Gu, Yanhong; Wang, Renjie; Yao, Qinghua; Xu, Yangxian; Wu, Jianyu; Jiang, Zhiwei; Chen, Kai; Hu, Wenwei; Tang, Dongxin; Huo, Jiege; Li, Ling; Bu, Qianqian; Zhao, Shuoqi; Zhang, Bei; Cheng, Haibo.
Afiliación
  • Geng X; The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wang Z; Department of General Surgery, Colorectal Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Feng L; Traditional Chinese Medicine Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Gu Y; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang R; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yao Q; Department of Integrated Chinese and Western Medicine, Institute of Basic Medicine and Cancer (IBMC), The Cancer HospitalUniversity of Chinese Academy of Sciences (Zhejiang Cancer Hospital)Chinese Academy of Sciences, Hangzhou, China.
  • Xu Y; Department of General Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Wu J; No. 2 Surgery Department, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangdong, China.
  • Jiang Z; Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Chen K; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Hu W; Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
  • Tang D; Clinical Medical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Huo J; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
  • Li L; Chinese Evidence-Based Medicine Center, NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Sichuan Center of Technology Innovation for Real World Data, West China Hospital, Sichuan University, Chengdu, China.
  • Bu Q; The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhao S; The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhang B; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. zhangbei@sysucc.org.cn.
  • Cheng H; Department of TCM, Sun Yat-Sen University Cancer Center, Guangzhou, China. zhangbei@sysucc.org.cn.
BMC Complement Med Ther ; 23(1): 239, 2023 Jul 17.
Article en En | MEDLINE | ID: mdl-37461034
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Calidad de Vida / Neoplasias del Colon Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: BMC Complement Med Ther Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Calidad de Vida / Neoplasias del Colon Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: BMC Complement Med Ther Año: 2023 Tipo del documento: Article País de afiliación: China